化学抗原受体为癌症治疗设计了天然杀手细胞
Yalan Zhang1, Weilin Zhou1, Jiangping Yang1,2
1Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, 610041, People's Republic of China.
Experimental hematology & oncology
|August 10, 2023
概括
自然杀手 (NK) 细胞被改造成化学抗原受体 (CAR) -NK细胞用于癌症治疗. 这些CAR-NK细胞在治疗血液癌症方面表现有前途,目前正在对固体瘤进行研究.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 自然杀手 (NK) 细胞是关键的先天性免疫细胞,可以消除压力和癌细胞.
- 使用NK细胞的采用细胞疗法已在癌症治疗中表现出有效性,因为它们具有杀死癌症的能力和安全性.
- 卡特-T细胞疗法的成功凸显了基因修饰免疫细胞在癌症治疗中的潜力.
研究的目的:
- 审查NK细胞作为基于CAR的工程平台的潜力.
- 总结关于CAR-NK细胞疗法的当前临床前和临床发现.
- 评估挑战,并为CAR-NK疗法提出未来的解决方案.
主要方法:
- 关于CAR-NK细胞疗法的现有文献的审查.
- 对临床前和临床试验数据的分析.
- 评估CAR-NK细胞发育中的战略和挑战.
主要成果:
- 作为一种有前途的癌症治疗方法,正在探索CAR-NK细胞,利用NK细胞的特性.
- 研究表明,针对针对各种癌症抗原的CAR-NK细胞具有显著的结果和安全性.
- CAR-NK细胞疗法在血液性恶性瘤中已经证明有效,但固体瘤应用正在芽.
结论:
- 在癌症免疫治疗中,NK细胞为基于CAR的工程提供了有利的概况.
- CAR-NK细胞疗法显示出显著的治疗潜力,特别是在血液癌症中.
- 需要进一步的研究来克服挑战,并推进对固体瘤的CAR-NK细胞疗法.
更多相关视频
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
879
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
650
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
